SCHEMBL13675485

SCHEMBL13675485

COc1ccc(NC(=O)c2cccc(-c3csc(N)n3)c2)cc1C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
POLB P06746 2/20 0.52
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
MAPT P10636 4/20 0.49
TP53 P04637 1/20 0.49
ADORA3 P0DMS8 1/20 0.48
PGR P06401 1/20 0.48
AR P10275 1/20 0.48
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
GAA P10253 2/20 0.48
NPSR1 Q6W5P4 1/20 0.48
MAPK14 Q16539 2/20 0.48
ALDH1A1 P00352 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
FBP1 P09467 1/20 0.47
SYK P43405 1/20 0.47
NFKB1 P19838 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4433867 0.89 SMN1; SMN2 (0.60) MEN1KMT2APOLBCYP1A2CYP3A4
SCHEMBL14300432 0.80 NPC1 (0.60) MEN1KMT2APOLBCYP1A2CYP3A4
SCHEMBL2739995 0.78 MAPT (0.65) MEN1KMT2APOLBMAPTTP53
SCHEMBL12205437 0.77 KCNK3 (0.67) MEN1KMT2APOLBMAPTTP53
SCHEMBL5328182 0.77 RAB9A (0.71) MEN1KMT2APOLBMAPTTP53
SCHEMBL23846564 0.77 HCRTR1 (0.50) MEN1KMT2APOLBMAPTTP53
SCHEMBL14274810 0.76 SMN1; SMN2 (0.57) MEN1KMT2APOLBCYP1A2CYP3A4
SCHEMBL3938751 0.76 FBP1 (0.55) MEN1KMT2APOLBCYP3A4MAPT
SCHEMBL28922759 0.75 RAB9A (0.66) MEN1KMT2AMAPTTP53PGR
Bromide SCHEMBL8360818 0.75 RAB9A (0.69) MEN1KMT2APOLBMAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7605264-B2 Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof BRISTOL-MYERS SQUIBB COMPANY (US) 2009-10-20 US disclosed